← Evidence map

ArticleAlimentary pharmacology & therapeutics2017

Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply.

V Jairath et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 28326588